These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6105787)
21. Roles of dopamine and its receptors in generation of choreic movements. Kanazawa I; Murata M; Kimura M Adv Neurol; 1993; 60():107-12. PubMed ID: 8093572 [TBL] [Abstract][Full Text] [Related]
22. [Some pharmacological aspects of neuroleptics (author's transl)]. Niemegeers CJ Encephale; 1981; 7(3):215-24. PubMed ID: 6116591 [TBL] [Abstract][Full Text] [Related]
23. New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations. Högberg T; Rämsby S; Ogren SO; Norinder U Acta Pharm Suec; 1987; 24(6):289-328. PubMed ID: 2898864 [No Abstract] [Full Text] [Related]
24. [Correlation of dopamin- and GABA-ergic mechanisms in the depressive effect of neuroleptics on pedal self-stimulation of the ventral tegmentum of the mesencephalon]. Talalaenko AN; Boreĭsha IK Farmakol Toksikol; 1983; 46(2):36-9. PubMed ID: 6133777 [TBL] [Abstract][Full Text] [Related]
25. Evidence for drug actions on both pre- and postsynaptic catecholamine receptors in the CNS. Bunney BS; Aghajanian GK Psychopharmacol Bull; 1975 Oct; 11(4):8-10. PubMed ID: 724 [No Abstract] [Full Text] [Related]
26. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain]. Matsubara R Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976 [TBL] [Abstract][Full Text] [Related]
27. Retrograde signaling at central synapses via endogenous cannabinoids. Kano M; Ohno-Shosaku T; Maejima T Mol Psychiatry; 2002; 7(3):234-5. PubMed ID: 11920149 [No Abstract] [Full Text] [Related]
28. [3H]Sulpiride, a ligand for neuroleptic receptors. Freedman SB; Poat JA; Woodruff GN Neuropharmacology; 1981 Dec; 20(12B):1323-6. PubMed ID: 6119644 [No Abstract] [Full Text] [Related]
29. [Molecular structures of anticonvulsants: molecular neurobiology of epilepsy]. Böhme I; Lüddens H Pharm Unserer Zeit; 2007; 36(4):262-8. PubMed ID: 17623315 [No Abstract] [Full Text] [Related]
31. Pharmacological and biochemical evidence for an interaction between the benzodiazepine and GABA receptors. Guidotti A Adv Biochem Psychopharmacol; 1980; 21():271-5. PubMed ID: 6246742 [No Abstract] [Full Text] [Related]
32. Modulation of dopamine receptor binding by ascorbic acid. Madras BK; Chan B Adv Biochem Psychopharmacol; 1983; 37():275-87. PubMed ID: 6138950 [No Abstract] [Full Text] [Related]
33. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553 [TBL] [Abstract][Full Text] [Related]
34. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes. Singh AN; Barlas C; Singh S; Franks P; Mishra RK J Psychiatry Neurosci; 1996 Jan; 21(1):29-35. PubMed ID: 8580115 [TBL] [Abstract][Full Text] [Related]